AU5983900A - Combined preparations comprising antitumor agents - Google Patents

Combined preparations comprising antitumor agents

Info

Publication number: AU5983900A
Authority: AU; Australia
Prior art keywords: antitumor agents; combined preparations; preparations; combined; antitumor
Prior art date: 1999-07-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU59839/00A

Inventor

Michele Caruso

Cristina Geroni

Marina Ripamonti

Antonino Suarato

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Italia SRL

Original Assignee

Pharmacia and Upjohn SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-20

Filing date

2000-07-10

Publication date

2001-02-05

2000-07-10 Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA

2001-02-05 Publication of AU5983900A publication Critical patent/AU5983900A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU59839/00A 1999-07-20 2000-07-10 Combined preparations comprising antitumor agents Abandoned AU5983900A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9917012		1999-07-20
GBGB9917012.8A GB9917012D0 (en)	1999-07-20	1999-07-20	Combined preparations comprising antitumor agents
PCT/EP2000/006540 WO2001005425A2 (en)	1999-07-20	2000-07-10	Combined preparations comprising daunorubicin derivatives and her2 antibodies

Publications (1)

Publication Number	Publication Date
AU5983900A true AU5983900A (en)	2001-02-05

Family

ID=10857596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU59839/00A Abandoned AU5983900A (en)	1999-07-20	2000-07-10	Combined preparations comprising antitumor agents

Country Status (5)

Country	Link
EP (1)	EP1200098A2 (en)
JP (1)	JP2003504413A (en)
AU (1)	AU5983900A (en)
GB (1)	GB9917012D0 (en)
WO (1)	WO2001005425A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6949245B1 (en)	1999-06-25	2005-09-27	Genentech, Inc.	Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
US7041292B1 (en)	1999-06-25	2006-05-09	Genentech, Inc.	Treating prostate cancer with anti-ErbB2 antibodies
KR20080038458A (en)	2000-05-19	2008-05-06	제넨테크, 인크.	Genetic detection assays to improve the likelihood of an effective response to cancer therapy with ERW antagonists
GB0114654D0 (en) *	2001-06-15	2001-08-08	Pharmacia & Upjohn Spa	Anti-tumor compound
PL1846030T3 (en)	2005-01-21	2019-05-31	Genentech Inc	Fixed dosing of her antibodies
EP3195879A1 (en)	2005-02-23	2017-07-26	Genentech, Inc.	Extending time to disease progression or survival in cancer patients
WO2008109440A2 (en)	2007-03-02	2008-09-12	Genentech, Inc.	Predicting response to a her dimerisation inhibitor based on low her3 expression
EP2592156B1 (en)	2007-06-08	2016-04-20	Genentech, Inc.	Gene expression markers of tumor resistance to HER2 inhibitor treatment
US9551033B2 (en)	2007-06-08	2017-01-24	Genentech, Inc.	Gene expression markers of tumor resistance to HER2 inhibitor treatment
BRPI0812682A2 (en)	2008-06-16	2010-06-22	Genentech Inc	metastatic breast cancer treatment
AR075896A1 (en)	2009-03-20	2011-05-04	Genentech Inc	ANTI-HER ANTIBODIES (EPIDERMAL GROWTH FACTOR)
WO2010136569A1 (en)	2009-05-29	2010-12-02	F. Hoffmann-La Roche Ag	Modulators for her2 signaling in her2 expressing patients with gastric cancer
CA2784211C (en)	2010-02-18	2019-12-24	Genentech, Inc.	Neuregulin antagonists and use thereof in treating cancer
WO2011146568A1 (en)	2010-05-19	2011-11-24	Genentech, Inc.	Predicting response to a her inhibitor
WO2012069466A1 (en)	2010-11-24	2012-05-31	Novartis Ag	Multispecific molecules
SG191153A1 (en)	2010-12-23	2013-07-31	Hoffmann La Roche	Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
CN103890007A (en)	2011-08-17	2014-06-25	霍夫曼-拉罗奇有限公司	Neuregulin antibodies and uses thereof
US9327023B2 (en)	2011-10-25	2016-05-03	The Regents Of The University Of Michigan	HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells
WO2013081645A2 (en)	2011-11-30	2013-06-06	Genentech, Inc.	Erbb3 mutations in cancer
EP2788500A1 (en)	2011-12-09	2014-10-15	F.Hoffmann-La Roche Ag	Identification of non-responders to her2 inhibitors
JP2015514710A (en)	2012-03-27	2015-05-21	ジェネンテック，インコーポレイテッド	Diagnosis and treatment of HER3 inhibitors
CA2889298C (en)	2012-11-30	2024-01-02	Anton Belousov	Identification of patients in need of pd-l1 inhibitor cotherapy
EP3454863A1 (en)	2016-05-10	2019-03-20	INSERM (Institut National de la Santé et de la Recherche Médicale)	Combinations therapies for the treatment of cancer
US10167342B2 (en)	2016-08-29	2019-01-01	Fazel Shokri	Production of hersintuzumab: a new humanized antibody against HER2 for cancer treatment
PT110526B (en)	2018-01-26	2021-02-04	Univ Nova De Lisboa	ANTIBODY, FUNCTIONAL FRAGMENT OR PROBE OF THE SAME AGAINST TUMORAL ANTIGENS
CN116368154A (en)	2020-10-08	2023-06-30	阿菲姆德股份有限公司	trispecific binder
AU2022320948A1 (en)	2021-07-30	2024-01-18	Affimed Gmbh	Duplexbodies
WO2023078968A1 (en)	2021-11-03	2023-05-11	Affimed Gmbh	Bispecific cd16a binders
WO2025257588A1 (en)	2024-06-10	2025-12-18	Affimed Gmbh	Cd16a/tumor antigen polyspecific binder for use in the treatment of immune checkpoint inhibitor resistance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989006692A1 (en) *	1988-01-12	1989-07-27	Genentech, Inc.	Method of treating tumor cells by inhibiting growth factor receptor function
FI102355B1 (en) *	1988-02-11	1998-11-30	Bristol Myers Squibb Co	Process for Preparation of Anthracycline Immunoconjugates with a Linking Link
US5705157A (en) *	1989-07-27	1998-01-06	The Trustees Of The University Of Pennsylvania	Methods of treating cancerous cells with anti-receptor antibodies
ZA9811162B (en) *	1997-12-12	2000-06-07	Genentech Inc	Treatment with anti-ERBB2 antibodies.
DE60041808D1 (en) *	1999-01-27	2009-04-30	Cornell Res Foundation Inc	TREATMENT OF CANCER WITH HER-2 / NEU OVEREXPRIMATION
US6333348B1 (en) *	1999-04-09	2001-12-25	Aventis Pharma S.A.	Use of docetaxel for treating cancers
WO2000069460A1 (en) *	1999-05-14	2000-11-23	Genentech, Inc.	TREATMENT WITH ANTI-ErbB2 ANTIBODIES

1999
- 1999-07-20 GB GBGB9917012.8A patent/GB9917012D0/en not_active Ceased
2000
- 2000-07-10 EP EP00945903A patent/EP1200098A2/en not_active Withdrawn
- 2000-07-10 AU AU59839/00A patent/AU5983900A/en not_active Abandoned
- 2000-07-10 WO PCT/EP2000/006540 patent/WO2001005425A2/en not_active Ceased
- 2000-07-10 JP JP2001510479A patent/JP2003504413A/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1200098A2 (en)	2002-05-02
WO2001005425A2 (en)	2001-01-25
GB9917012D0 (en)	1999-09-22
JP2003504413A (en)	2003-02-04
WO2001005425A3 (en)	2001-05-17

Publication	Publication Date	Title
AU5983900A (en)	2001-02-05	Combined preparations comprising antitumor agents
AUPQ105499A0 (en)	1999-07-08	Antiviral agents
AU1225000A (en)	2000-05-15	Combined pharmaceutical estrogen-androgen-progestin
AU2002224595A1 (en)	2002-02-13	Antitumor agents
AU2557600A (en)	2000-08-29	Skin lightening agents
AU4397700A (en)	2000-11-17	Combined preparations comprising anthracycline derivatives
AUPQ288499A0 (en)	1999-10-07	Antiviral agents
AU2451500A (en)	2000-09-04	Therapeutic agents
AU4090299A (en)	1999-12-06	Liposomal delivery complex
AU1554301A (en)	2001-06-12	Radioprotecting agent
AU3929799A (en)	1999-12-06	Effervescent preparations
AU7446000A (en)	2001-04-30	Antitumor agents
AU5973600A (en)	2001-01-31	Therapeutic agents
HUP0200483A3 (en)	2004-07-28	Liposome preparations
AU2231601A (en)	2001-07-09	Vancomycin preparations
AU3191100A (en)	2000-10-04	Ligand-bonded complex
AU1800100A (en)	2000-07-31	Medicinal preparations
AU2001282521A1 (en)	2002-06-06	OCT preparations
AU2001272427A1 (en)	2001-12-17	Solid preparations
AU4504201A (en)	2001-06-12	Drug preparations
AU6150200A (en)	2001-01-31	Therapeutic agents
AU3158301A (en)	2001-07-03	Decorative cosmetic preparations
AU2998399A (en)	1999-11-01	Anticancer agents
AU4746300A (en)	2000-11-14	Cosmetic preparations
AU3964700A (en)	2000-11-14	Cosmetic preparations

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase